Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W C Nichols

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Mammalian Genome : Official Journal of the International Mammalian Genome Society|January 1, 1993
Conserved linkage of neurotrophin-3 and von Willebrand factor on mouse chromosome 6L L Barrow, K Simin, K Mohlke, et al.
The Journal of Biological Chemistry|November 7, 1999
Mannose-dependent endoplasmic reticulum (ER)-Golgi intermediate compartment-53-mediated ER to Golgi trafficking of coagulation factors V and VIIIM Moussalli, S W Pipe, H P Hauri, et al.
Cancer Treatment Reports|January 1, 1980
Phase II evaluation of AMSA in patients with metastatic lung cancerW C Nichols, R T Eagan, S Frytak, et al.
Cancer Clinical Trials|January 1, 1981
A case for preplanned thoracic and prophylactic whole brain radiation therapy in limited small-cell lung cancerR T Eagan, S Frytak, R E Lee, et al.
Cancer Treatment Reports|May 1, 1981
Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancerR T Eagan, S Frytak, W C Nichols, et al.
The Journal of Pediatrics|May 1, 1996
Neonatal purpura fulminans in association with factor V R506Q mutationS W Pipe, A H Schmaier, W C Nichols, et al.
Cancer Treatment Reports|August 1, 1980
Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lungR T Eagan, S Frytak, J N Ingle, et al.
Cancer Treatment Reports|May 1, 1981
Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancersR T Eagan, S Frytak, W C Nichols, et al.
Cancer|June 1, 1983
Cis-diamminedichloroplatinum (II) administered by 24-hour infusion in the treatment of patients with advanced upper aerodigestive cancerE T Creagan, J R O'Fallon, J E Woods, et al.
Cancer Clinical Trials|January 1, 1981
Thoracic radiation therapy and Adriamycin/cisplatin-containing chemotherapy for locally advanced non-small-cell lung cancerR T Eagan, R E Lee, S Frytak, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Mammalian Genome : Official Journal of the International Mammalian Genome Society|January 1, 1993
Conserved linkage of neurotrophin-3 and von Willebrand factor on mouse chromosome 6L L Barrow, K Simin, K Mohlke, et al.
The Journal of Biological Chemistry|November 7, 1999
Mannose-dependent endoplasmic reticulum (ER)-Golgi intermediate compartment-53-mediated ER to Golgi trafficking of coagulation factors V and VIIIM Moussalli, S W Pipe, H P Hauri, et al.
Cancer Treatment Reports|January 1, 1980
Phase II evaluation of AMSA in patients with metastatic lung cancerW C Nichols, R T Eagan, S Frytak, et al.
Cancer Clinical Trials|January 1, 1981
A case for preplanned thoracic and prophylactic whole brain radiation therapy in limited small-cell lung cancerR T Eagan, S Frytak, R E Lee, et al.
Cancer Treatment Reports|May 1, 1981
Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancerR T Eagan, S Frytak, W C Nichols, et al.
The Journal of Pediatrics|May 1, 1996
Neonatal purpura fulminans in association with factor V R506Q mutationS W Pipe, A H Schmaier, W C Nichols, et al.
Cancer Treatment Reports|August 1, 1980
Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lungR T Eagan, S Frytak, J N Ingle, et al.
Cancer Treatment Reports|May 1, 1981
Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancersR T Eagan, S Frytak, W C Nichols, et al.
Cancer|June 1, 1983
Cis-diamminedichloroplatinum (II) administered by 24-hour infusion in the treatment of patients with advanced upper aerodigestive cancerE T Creagan, J R O'Fallon, J E Woods, et al.
Cancer Clinical Trials|January 1, 1981
Thoracic radiation therapy and Adriamycin/cisplatin-containing chemotherapy for locally advanced non-small-cell lung cancerR T Eagan, R E Lee, S Frytak, et al.
Pageof 8